Literature DB >> 16183929

Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats.

Douglas L Miller1, Peng Li, Chunyan Dou, David Gordon, Chris A Edwards, William F Armstrong.   

Abstract

PURPOSE: To detect specific cardiomyocyte injury induced by myocardial contrast material-enhanced echocardiography (ie, myocardial contrast echocardiography) in rats and to ascertain the influences of contrast material dose and ultrasound exposure on this injury.
MATERIALS AND METHODS: All animal procedures were approved by the university committee for the use and care of animals. Myocardial contrast echocardiography with 1:4 electrocardiographic (ECG) triggering was performed at 1.5 MHz in 61 anesthetized rats. Evans blue (EB) dye was injected as the vital stain for cardiomyocyte injury. At the start of myocardial contrast echocardiography, which lasted 10 minutes, perflutren lipid microsphere-based contrast material was infused through the tail vein for 5 minutes. Premature heartbeats were counted from the ECG record. The numbers of EB-stained cells counted on sections of heart specimens obtained 24 hours after myocardial contrast echocardiography and then either fresh frozen or embedded in paraffin were determined by using fluorescence microscopy. Results were compared statistically by using t tests and Mann-Whitney rank sum tests.
RESULTS: EB-stained cells were concentrated in the anterior region of the myocardium. In the paraffin-embedded specimens, EB-stained cells were often accompanied by but largely separate from areas of inflammatory cell infiltration. At end-systolic triggering with a 50 microL/kg dose of microsphere contrast material, the EB-stained cell count increased with increasing peak rarefactional pressure amplitude, with significantly increased cell counts at 1.6 MPa (P < .02) and 2.0 MPa (P < .005) relative to the cell counts at sham myocardial contrast echocardiography. Premature heartbeats had a similar exposure-response relationship; however, number of premature heartbeats and EB-stained cell count did not appear to be directly related (coefficient of determination r2 = 0.03). The EB-stained cell counts at end-diastolic triggering were not significantly different from those at end-systolic triggering (P > .1). EB-stained cell counts increased with increasing contrast material dose, from 10 to 50 microL/kg, at 2.0 MPa.
CONCLUSION: Cardiomyocyte injury was induced by the interaction of ultrasound pulses with contrast agent microbubbles during myocardial contrast echocardiography in rats, and the numbers of injured cells increased with increasing contrast agent dose and ultrasound exposure. RSNA, 2005

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183929     DOI: 10.1148/radiol.2371041467

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  30 in total

1.  Evans blue staining of cardiomyocytes induced by myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis.

Authors:  Douglas L Miller; Peng Li; Chunyan Dou; William F Armstrong; David Gordon
Journal:  Ultrasound Med Biol       Date:  2007-08-06       Impact factor: 2.998

Review 2.  Microbubbles in ultrasound-triggered drug and gene delivery.

Authors:  Sophie Hernot; Alexander L Klibanov
Journal:  Adv Drug Deliv Rev       Date:  2008-04-03       Impact factor: 15.470

3.  Acoustic attenuation by contrast agent microbubbles in superficial tissue markedly diminishes petechiae bioeffects in deep tissue.

Authors:  Ji Song; Alexander L Klibanov; John A Hossack; Richard J Price
Journal:  Invest Radiol       Date:  2008-05       Impact factor: 6.016

4.  Production of uniformly sized serum albumin and dextrose microbubbles.

Authors:  Michael J Borrelli; William D O'Brien; Laura J Bernock; Heather R Williams; Eric Hamilton; Jonah Wu; Michael L Oelze; William C Culp
Journal:  Ultrason Sonochem       Date:  2011-05-27       Impact factor: 7.491

5.  Markedly enhanced skeletal muscle transfection achieved by the ultrasound-targeted delivery of non-viral gene nanocarriers with microbubbles.

Authors:  Caitlin W Burke; Jung Soo Suk; Anthony J Kim; Yu-Han J Hsiang; Alexander L Klibanov; Justin Hanes; Richard J Price
Journal:  J Control Release       Date:  2012-07-16       Impact factor: 9.776

6.  Characterization of macrolesions induced by myocardial cavitation-enabled therapy.

Authors:  Yiying I Zhu; Douglas L Miller; Chunyan Dou; Oliver D Kripfgans
Journal:  IEEE Trans Biomed Eng       Date:  2014-10-22       Impact factor: 4.538

Review 7.  Ultrasound-induced blood-brain barrier opening.

Authors:  Elisa E Konofagou; Yao-Sheng Tung; James Choi; Thomas Deffieux; Babak Baseri; Fotios Vlachos
Journal:  Curr Pharm Biotechnol       Date:  2012-06       Impact factor: 2.837

8.  Optimization of ultrasound parameters of myocardial cavitation microlesions for therapeutic application.

Authors:  Douglas L Miller; Chunyan Dou; Gabe E Owens; Oliver D Kripfgans
Journal:  Ultrasound Med Biol       Date:  2014-03-06       Impact factor: 2.998

9.  Development of therapeutic microbubbles for enhancing ultrasound-mediated gene delivery.

Authors:  Ryan R Sun; Misty L Noble; Samuel S Sun; Shuxian Song; Carol H Miao
Journal:  J Control Release       Date:  2014-03-18       Impact factor: 9.776

10.  The arrhythmogenic effect of ultrasonic exposure with acoustic radiation force (ARF) impulse on the rabbit heart with ultrasound contrast agent perfluorobutane.

Authors:  Yasunao Ishiguro; Hideki Sasanuma; Naotaka Nitta; Nobuyuki Taniguchi; Yukiyo Ogata; Yoshikazu Yasuda; Iwaki Akiyama
Journal:  J Med Ultrason (2001)       Date:  2014-09-19       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.